BTIG Sees Strategic Value in CrowdStrike’s (CRWD) SGNL, Seraphic Acquisitions

CrowdStrike Holdings, Inc. (NASDAQ:CRWD) is one of the Trending AI Stocks on Wall Street. On January 13, BTIG analyst Gray ...

FDA Acknowledges Effects on Pain Intensity Favor Rexlemestrocel-L, Confirms 12-Month Reduction in Back Pain Supports Product Efficacy

FDA has designated rexlemestrocel-L a Regenerative Medicine Advanced Therapy (RMAT) for the treatment of chronic low back pain. RMAT designation provides all the benefits of Breakthrough and Fast ...

Mesoblast Limited: FDA Acknowledges Effects on Pain Intensity Favor Rexlemestrocel-L, Confirms 12-Month Reduction in Back Pain Supports Product Efficacy

Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today provided feedback received from the ...

Nxera Pharma Reports Positive Results From Phase 3 Trial of Daridorexant in South Korea

Daridorexant is a dual orexin receptor antagonist being developed by Nxera for the treatment of adult patients with insomnia and is approved and marketed in Japan as QUVIVIQ®Phase 3 trial of ...
Scientific Research Publishing

Hydrogels in Drug Delivery: Past Developments, Current Innovations, and Future Directions ()

Hydrogels are among the most widely studied biomaterials in modern drug delivery research. Their high hydrophilicity, ...